Zymeworks (ZYME) Stock Forecast & Price Target
Score
Zymeworks Inc. price target
| ZYME | |
|---|---|
| Low | $32.00 |
| Average | $43.33 |
| High | $55.00 |
| Upside vs current price | +63.8% |
The average target of $43.33 is +63.8% versus the current ZYME price of $26.45.
Zymeworks Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 2 |
| Buy | 12 |
| Hold | 0 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
14 analysts cover ZYME.
Zymeworks Inc. EPS and revenue estimates
The estimate table for the Zymeworks Inc. keeps 2026 EPS $1.19, 2027 EPS $1.32, and years with fewer than three analysts are not filled in.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $1.19 | $302.70M |
| 2027 | $1.32 | $353.75M |
Is Zymeworks Inc. a buy or sell?
Of the 14 analysts covering Zymeworks Inc., 14 rate it a buy (2 strong buy and 12 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The ZYME consensus label is Buy, beside 14 buy-side ratings and 0 sell-side ratings.
The average target of $43.33 implies +63.8% versus the current price of $26.45.
the Zymeworks Inc. closes with 14 buy-side ratings and 0 on the sell side. The headcount is Buy.
Reading the Zymeworks Inc. forecast
Analysts are far apart on ZYME. The published low is $32.00, the average is $43.33, and the high is $55.00.
From today's $26.45 print, the ZYME average target is +63.8% away.
Most of the ZYME coverage agrees: 14 of 14 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.
ZYME targets have been marked up: $43.50 across the last month versus $41.60 across the last quarter.
ZYME coverage is thin at 14 analysts, and one revision moves the average.
Zymeworks Inc. forecast questions
What is the ZYME price target?
The published range for ZYME is $32.00 to $55.00, with an average of $43.33. That average is +63.8% versus the current price of $26.45.
Is Zymeworks Inc. a buy or sell?
Of the 14 analysts covering Zymeworks Inc., 14 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for ZYME is 14 on the buy side, 0 at hold, and 0 on the sell side.
What is the EPS estimate for Zymeworks Inc.?
Analyst EPS estimates for Zymeworks Inc.: 2026 $1.19, 2027 $1.32.
What is the revenue estimate for Zymeworks Inc.?
Analyst revenue estimates for Zymeworks Inc.: 2026 $302.70M, 2027 $353.75M.
How many analysts cover ZYME?
14 analysts cover ZYME. Their consensus on ZYME is Buy, across those 14.